BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Niu M, Wei AW, Tang JF, Tu C, Bai ZF, Zou ZS, Xiao XH, Liu YP, Wang JB. Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Arch Toxicol 2020;94:245-56. [PMID: 31630224 DOI: 10.1007/s00204-019-02595-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Niu M, Jing J, Zhang ZT, Zhao X, Chen SS, Li SS, Shi Z, Huang A, Zou ZS, Yu YC, Xiao XH, Liangpunsakul S, Wang JB. Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol-Associated Liver Cirrhosis. Hepatol Commun 2021;5:961-75. [PMID: 34141983 DOI: 10.1002/hep4.1699] [Reference Citation Analysis]
2 Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. [PMID: 33641080 DOI: 10.1007/s12072-021-10144-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
3 Wang Y, Xu G, Wang Z, Li R, Zhan X, Liu H, Qin Q, Li W, Wang X, Zhang M, Tang J, Bai Z, Xiao X. Psoralidin, a major component of Psoraleae Fructus, induces inflammasome activation and idiosyncratic liver injury. Int Immunopharmacol 2021;92:107352. [PMID: 33422760 DOI: 10.1016/j.intimp.2020.107352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li SS, Niu M, Jing J, Huang Y, Zhang ZT, Chen SS, Shi GZ, He X, Zhang HZ, Xiao XH, Zou ZS, Yu YC, Wang JB. Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis. Front Med (Lausanne) 2021;8:644376. [PMID: 33777984 DOI: 10.3389/fmed.2021.644376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Xia Q, Wang J, Zhuang K, Jin H, Liu K. Progress in using zebrafish as a toxicological model for traditional Chinese medicine. J Ethnopharmacol 2022;282:114638. [PMID: 34530096 DOI: 10.1016/j.jep.2021.114638] [Reference Citation Analysis]
6 Li D, Lyu Y, Zhao J, Ji X, Zhang Y, Zuo Z. Accumulation of the Major Components from Polygoni Multiflori Radix in Liver and Kidney after Its Long-Term Oral Administrations in Rats. Planta Med 2021. [PMID: 34521133 DOI: 10.1055/a-1585-5991] [Reference Citation Analysis]
7 Zhai XR, Zou ZS, Wang JB, Xiao XH. Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics. Front Pharmacol 2021;12:738577. [PMID: 34539416 DOI: 10.3389/fphar.2021.738577] [Reference Citation Analysis]
8 Atallah E, Freixo C, Alvarez-Alvarez I, Cubero FJ, Gerbes AL, Kullak-Ublick GA, Aithal GP. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review. Expert Opin Drug Metab Toxicol 2021;:1-17. [PMID: 34727797 DOI: 10.1080/17425255.2021.1999410] [Reference Citation Analysis]
9 Tu C, Niu M, Wei AW, Tang JF, Zhang L, Jing J, Xiao XH, Wang JB. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. J Inflamm Res 2021;14:645-55. [PMID: 33692634 DOI: 10.2147/JIR.S299892] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xie Z, Zhang L, Chen E, Lu J, Xiao L, Liu Q, Zhu D, Zhang F, Xu X, Li L. Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury. Metabolites 2021;11:852. [PMID: 34940610 DOI: 10.3390/metabo11120852] [Reference Citation Analysis]
11 Tu C, Gao Y, Song D, Niu M, Ma RR, Zhou MX, He X, Xiao XH, Wang JB. Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics. Front Pharmacol 2021;12:693928. [PMID: 34630079 DOI: 10.3389/fphar.2021.693928] [Reference Citation Analysis]
12 Chen SS, Huang Y, Guo YM, Li SS, Shi Z, Niu M, Zou ZS, Xiao XH, Wang JB. Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis. Front Med (Lausanne) 2021;8:640799. [PMID: 33855035 DOI: 10.3389/fmed.2021.640799] [Reference Citation Analysis]
13 Smith L, Villaret-Cazadamont J, Claus SP, Canlet C, Guillou H, Cabaton NJ, Ellero-Simatos S. Important Considerations for Sample Collection in Metabolomics Studies with a Special Focus on Applications to Liver Functions. Metabolites 2020;10:E104. [PMID: 32178364 DOI: 10.3390/metabo10030104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
14 Xu L, Wang Y, Ma Z, Tang X, Gao Y. Urine Metabolomics Study on Potential Hepatoxic Biomarkers Identification in Rats Induced by Aurantio-Obtusin. Front Pharmacol 2020;11:1237. [PMID: 32903457 DOI: 10.3389/fphar.2020.01237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Woo SM, Davis WD, Aggarwal S, Clinton JW, Kiparizoska S, Lewis JH. Herbal and dietary supplement induced liver injury: Highlights from the recent literature. World J Hepatol 2021; 13(9): 1019-1041 [PMID: 34630872 DOI: 10.4254/wjh.v13.i9.1019] [Reference Citation Analysis]
16 He X, Zhou M, Cheng C, Li S, Gao Y, Ma Z, Song X, Bai Z, Zou Z, Xiao X, Wang J, Lu Y. Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury. Front Pharmacol 2022;13:896198. [DOI: 10.3389/fphar.2022.896198] [Reference Citation Analysis]